Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Sung, J. Ashouri, R. Zamanian, L. Chung (Stanford, Palo Alto, United States Of America). Immunosuppression in systemic lupus erythematosus associated pulmonary arterial hypertension (SLE-APAH): Improvement in exercise and functional capacity. Eur Respir J 2011; 38: Suppl. 55, 2394

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension and systemic lupus erythematosus Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Effectiveness of ²Korargin² in the therapy of pulmonary arterial hypertension in patients with systemic lupus erythematosus Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Endothelium dysfunction in systemic lupus erythematosus patients with pulmonary hypertension Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011 Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus Source: Eur Respir Rev 2011; 20: 277-286 Year: 2011 Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Raynaud phenomenon is correlated with systolic pulmonary arterial pressure in patients with systemic lupus erythematosus Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006 The nitroxidergic system state at systemic lupus erythematosus-associated pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Examining pulmonary function measures in patients with systemic lupus erythematosus (SLE) Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020 Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study Source: Eur Respir J, 53 (2) 1800081; 10.1183/13993003.00081-2018 Year: 2019 Cardio-pulmonary exercise testing in systemic lupus erythematosus patients Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005 The profile of lung scintigraphy in systemic lupus erythematosus with chronic pulmonary embolism:a cross-section Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 A functionally improved case of obstructive impairment caused by systemic lupus erythematosus Source: Breathe, 17 (2) 200288; 10.1183/20734735.0288-2020 Year: 2021 Pulmonary hypertension in systemic scleroderma Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Abnormalities on ventilatory efficiency during graded exercise test in juvenile systemic lupus erythematosus patients Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Lung abnormalities in patients with systemic lupus erythematosus Source: Eur Respir J 2001; 18: Suppl. 33, 225s Year: 2001 Management and prognosis of respiratory manifestations revealing systemic lupus erythematosus Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Pulmonary involvement in systemic lupus erythematosus, Sjögren syndrome and mixed connective tissue disease Source: Eur Respir Monogr 2019; 86: 106-123 Year: 2019 Pulmonary hypertension and arterial stiffness in patients with systemic scleroderma Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 Systemic lupus erythematosus-associated PAH: is targeting inflammation the key to success? Source: Eur Respir Rev 2011; 20: 218-219 Year: 2011 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006